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BACKGROUND Hypertension is characterized by a maintained high blood pressure
leading to cardiac complications such as left ventricular hypertrophy and fibrosis and
an increased risk of heart failure and myocardial infarction. This study investigated
the cardiac effects of oral administration of Moringa oleifera (MOI) seed powder in
spontaneous hypertensive rats (SHR).
METHODS SHR received food containing MOI seed powder (750mg/d, 8 weeks) or
normal food. In vivo measurement of hemodynamic parameters by telemetry and
cardiac structure and function analysis by echocardiography were performed.
Histological studies were performed to determine fibrosis and protein expression.
RESULTS MOI treatment did not modify blood pressure in SHR but reduced
nocturnal heart rate and improved cardiac diastolic function (reduction of
isovolumetric relaxation time and deceleration time of the E wave, increase of
ejection volume and cardiac output compared to nontreated SHR). Left ventricular
anterior wall thickness, interseptal thickness on diastole, and relative wall thickness
were reduced after MOI treatment. Furthermore, we found a significant reduction of
fibrosis in the left ventricle of MOI-treated SHR. This antihypertrophic and
antifibrotic effect of MOI was associated with increased expression of peroxisome
proliferator-activated receptor (PPAR)-α and δ, reduced cardiac triglyceride level,
and enhanced plasmatic prostacyclins.
CONCLUSIONS Our data show a beneficial effect of MOI on the cardiac structure
and function in SHR associated with an upregulation of PPAR-α and δ signaling. This
study thus provides scientific rational support for the empirical use of MOI in the
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